Blood-based high sensitivity measurements of beta-amyloid and phosphorylated tau as biomarkers of Alzheimer’s disease: a focused review on recent advancesJoyce R. Chong, Mitchell K.P. Lai, Kaj Blennow et al.|Journal of Neurology Neurosurgery & Psychiatry|2021Cited by 111
Plasma P‐tau181 to Aβ42 ratio is associated with brain amyloid burden and hippocampal atrophy in an Asian cohort of Alzheimer's disease patients with concomitant cerebrovascular diseaseJoyce R. Chong, Christopher Chen, Anthonin Reilhac et al.|Alzheimer s & Dementia|2021Cited by 99
Elevated Soluble TNF-Receptor 1 in the Serum of Predementia Subjects with Cerebral Small Vessel DiseaseKaung H. T. Salai, Mitchell K.P. Lai, Caroline Robert et al.|Biomolecules|2023Cited by 19
Associations of Circulating Platelet Endothelial Cell Adhesion Molecule‐1 Levels With Progression of Cerebral Small‐Vessel Disease, Cognitive Decline, and Incident DementiaMing Ann Sim, Christopher Chen, Caroline Robert et al.|Journal of the American Heart Association|2024Cited by 8
Interactive effect of diabetes mellitus and subclinical MRI markers of cerebrovascular disease on cognitive decline and incident dementia: a memory-clinic studyJiangbo Cui, Saima Hilal, Caroline Robert et al.|Alzheimer s Research & Therapy|2024Cited by 7